Join Seth Ettenberg, Unum Therapeutics' Chief Scientific Officer at BIO 2018
Unum Therapeutics' Chief Scientific Officer, Seth Ettenberg, will be participating in a panel "Engineered Living Medicines: The Next Wave of Novel Therapeutics for Patients" at the BIO Convention in Boston, MA. Also on the panel will be Aoife Brennan, Interim President & CEO Synlogic, Inc., and Bastiano Sanna, President & CEO Semma Therapeutics. The panel will be moderated by James Collins, Henri Termeer Professor of Medical Engineering & Science at MIT.
Join us for an exciting discussion on the future of engineered living medicines at the BIO Convention June 4th 4:00 pm to 5:00 pm, Room 210B, Level 2 at the Boston Convention & Exhibition Center 415, Summer St. #BIO2018